| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/2011 | WO2011075725A1 Methods and compositions related to clot-binding compounds |
| 06/23/2011 | WO2011075691A1 Methods and compositions for stable liquid drug formulations |
| 06/23/2011 | WO2011075685A1 Ophthalmic solutions with improved disinfection profiles |
| 06/23/2011 | WO2011075656A1 Methods and compositions for delivery of nucleic acids |
| 06/23/2011 | WO2011075623A1 One - phase gel compos ition compri s ing phos pholi pids |
| 06/23/2011 | WO2011075516A2 Active scaffolds for on-demand drug and cell delivery |
| 06/23/2011 | WO2011075481A1 Intracameral devices for sustained delivery |
| 06/23/2011 | WO2011074961A1 Co-processed tablet excipient composition its preparation and use |
| 06/23/2011 | WO2011074851A2 Pharmaceutical preparation |
| 06/23/2011 | WO2011074791A2 Pharmaceutical composition containing telmisartan and hydrochlorothiazide |
| 06/23/2011 | WO2011074782A2 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine |
| 06/23/2011 | WO2011074743A1 Granules comprising fenofibrate adsorbed on carrier surface and pharmaceutical composition comprising the same |
| 06/23/2011 | WO2011074670A1 Liquid food composition |
| 06/23/2011 | WO2011074660A1 Elution-stabilized preparation |
| 06/23/2011 | WO2011074652A1 Nucleic acid capable of inhibiting expression of hif-2α |
| 06/23/2011 | WO2011074637A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074636A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074635A1 Transdermally absorbed preparation of anti-dementia drug |
| 06/23/2011 | WO2011074578A1 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability |
| 06/23/2011 | WO2011074567A1 Transdermal preparation containing basic anti-inflammatory agent |
| 06/23/2011 | WO2011074566A1 Felbinac-containing transdermal absorption preparation |
| 06/23/2011 | WO2011074565A1 Piroxicam-containing endermic preparation |
| 06/23/2011 | WO2011074015A2 Novel composition of pharmaceutical product to treat sexual dysfunction |
| 06/23/2011 | WO2011073998A1 Composition of dexibuprofen transdermal hydrogel |
| 06/23/2011 | WO2011073995A2 Liquid vaginal spray of progesterone |
| 06/23/2011 | WO2011073726A1 Nanoemulsion, method for its preparation and use |
| 06/23/2011 | WO2011073685A1 Modulator |
| 06/23/2011 | WO2011073408A2 Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
| 06/23/2011 | WO2011073395A1 Antifungal composition intended to be applied to a perforated nail |
| 06/23/2011 | WO2011073392A1 Use of a cationic, advantageously amphoteric, surfactant for the preparation of an antifungal solution that can be applied to the nail |
| 06/23/2011 | WO2011073245A2 Granules for pharmaceutical preparations, methods and apparatus for their production |
| 06/23/2011 | WO2011073234A2 Growth hormone composition |
| 06/23/2011 | WO2011073229A1 Compositions comprising alginates with high guluronic acid/mannuronic acid ratio for use in the treatment of dentine hypersensitivity |
| 06/23/2011 | WO2011073002A1 Antibiotic microparticles for inhalation |
| 06/23/2011 | WO2011072861A1 Suppository comprising pantoprazole |
| 06/23/2011 | WO2011072839A1 Orodispersible tablet, containing dapoxetine |
| 06/23/2011 | WO2011072619A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof |
| 06/23/2011 | WO2011072557A1 ALGINATE-ε-POLYLYSINE MICROCAPSULE, ITS PREPARATION METHOD AND APPLICATION |
| 06/23/2011 | WO2011072509A1 Progesterone formulation composition and preparation method thereof |
| 06/23/2011 | WO2011072481A1 Controlled release tablet formed by multiple particles |
| 06/23/2011 | WO2011072474A1 Double-layer osmotic pump controlled release tablet of bicyclol and preparation method thereof |
| 06/23/2011 | WO2011072399A1 Injectable polymer composition for use as a cell delivery vehicle |
| 06/23/2011 | WO2011072398A1 Local delivery of drugs from self assembled coatings |
| 06/23/2011 | WO2011072320A1 Effervescent l-carnitine-based composition |
| 06/23/2011 | WO2011053139A3 Aqueous composition for topical application, method of preparation, uses and device |
| 06/23/2011 | WO2011051924A3 Method of wound treatment using liquid gallium nitrate |
| 06/23/2011 | WO2011030166A9 The use of lipid emulsions for binding hepatitis c virus |
| 06/23/2011 | WO2011028334A3 Synthesis and isolation of dendrimer systems |
| 06/23/2011 | WO2011027990A9 Extracellular vesicles derived from gram-positive bacteria, and use thereof |
| 06/23/2011 | WO2011027365A3 Ophthalmic compositions containing dorzolamide, timolol and brimonidine |
| 06/23/2011 | WO2011027174A3 Composition |
| 06/23/2011 | WO2011025035A9 Coating composition |
| 06/23/2011 | WO2011018504A3 Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| 06/23/2011 | WO2011014588A3 Dermal formulations of dp2 receptor antagonists |
| 06/23/2011 | WO2011000489A3 Novel esters, and use thereof |
| 06/23/2011 | WO2010125475A3 Sustained release formulations comprising gnrh analogues |
| 06/23/2011 | WO2010089775A3 Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent |
| 06/23/2011 | WO2010061193A3 Compositions with reduced dimer formation |
| 06/23/2011 | US20110152335 Allantoin-containing skin cream |
| 06/23/2011 | US20110152307 Ophthalmic composition comprising ascomycin |
| 06/23/2011 | US20110152294 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising osmolyte as active agent component |
| 06/23/2011 | US20110152216 Anaesthetic composition |
| 06/23/2011 | US20110152201 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 06/23/2011 | US20110152198 Pharmaceutical compositions containing botulinum toxin |
| 06/23/2011 | US20110152190 Erodible polymers for injection |
| 06/23/2011 | US20110151103 System and a Method for Pharmaceutical Dosage Preparation Using Jettable Microemulsions |
| 06/23/2011 | US20110151019 Heat Generating Nanomaterials |
| 06/23/2011 | US20110151015 Immunomodulator particles and methods of treating |
| 06/23/2011 | US20110151014 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients |
| 06/23/2011 | US20110151013 Amphiphilic block copolymers for nucleic acid delivery |
| 06/23/2011 | US20110151012 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents |
| 06/23/2011 | US20110151011 Decellularized Adipose Tissue |
| 06/23/2011 | US20110151010 Anti-snoring treatment comprising positively charged multilamellar microparticles |
| 06/23/2011 | US20110151009 Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 06/23/2011 | US20110151008 Pulmonary Delivery for Levodopa |
| 06/23/2011 | US20110151007 Carbide-derived-carbon-based oxygen carriers |
| 06/23/2011 | US20110151006 Stimuli-responsive hydrogel |
| 06/23/2011 | US20110151005 Methods and means for soft tissue engineering |
| 06/23/2011 | US20110151004 Injectable Microspheres |
| 06/23/2011 | US20110151003 Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
| 06/23/2011 | US20110151002 Sustained release pharmaceutical compositions comprising quetiapine |
| 06/23/2011 | US20110151001 Pharmaceutical composition for external application containing prochlorperazine |
| 06/23/2011 | US20110151000 Nitric oxide-releasing compositions, devices and methods |
| 06/23/2011 | US20110150998 Methods For Producing ECM-Based Biomaterials |
| 06/23/2011 | US20110150997 Elvucitabine pharmaceutical compositions |
| 06/23/2011 | US20110150996 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino] -2-pyrimidinyl]amino]benzonitrile |
| 06/23/2011 | US20110150995 Solid Dosage Forms of Essential Oils |
| 06/23/2011 | US20110150994 Modified Release Formulation |
| 06/23/2011 | US20110150993 Fine Particle Croscarmellose and Uses Thereof |
| 06/23/2011 | US20110150992 Quinine formulations, method of making, and method of use thereof |
| 06/23/2011 | US20110150991 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150990 Abuse resistant drugs, method of use and method of making |
| 06/23/2011 | US20110150989 Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| 06/23/2011 | US20110150988 Dietary supplement composition for blood lipid health |
| 06/23/2011 | US20110150987 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance |
| 06/23/2011 | US20110150986 Quinine formulations, method of making, and metho of use thereof |
| 06/23/2011 | US20110150985 Methods for preparing pharmaceuticals by emulsion aggregation processes |
| 06/23/2011 | US20110150984 Methods of increasing the bioavailability and/or cellular update of drugs |
| 06/23/2011 | US20110150983 Concentrated, inhalable ciprofloxacin formulation |
| 06/23/2011 | US20110150982 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |